Shareholder Alert: Ademi LLP investigates whether Pulmatrix, Inc. is obtaining a Fair Price for its Public Shareholders

Audio By Carbonatix

MILWAUKEE--(BUSINESS WIRE)--Nov 13, 2024--

Ademi LLP is investigating Pulmatrix (Nasdaq: PULM) for possible breaches of fiduciary duty and other violations of law in its transaction with Cullgen .

Click here to learn how to join our investigation and obtain additional information or contact us at [email protected] or toll-free: 866-264-3995. There is no cost or obligation to you.

In the transaction, Pulmatrix stockholders are expected to own approximately 3.6% of the combined company, and pre-merger Cullgen stockholders are expected to own approximately 96.4% of the combined company. The transaction agreement unreasonably limits competing transactions for Pulmatrix by imposing a significant penalty if Pulmatrix accepts a competing bid. Pulmatrix insiders will receive substantial benefits as part of change of control arrangements.

We are investigating the conduct of Pulmatrix’s board of directors, and whether they are fulfilling their fiduciary duties to all shareholders.

We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights throughout the country. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.

View source version on businesswire.com:https://www.businesswire.com/news/home/20241113326286/en/

CONTACT: Ademi LLP

Guri Ademi

Toll Free: (866) 264-3995

Fax: (414) 482-8001

KEYWORD: UNITED STATES NORTH AMERICA WISCONSIN

INDUSTRY KEYWORD: CLASS ACTION LAWSUIT PROFESSIONAL SERVICES LEGAL

SOURCE: Ademi LLP

Copyright Business Wire 2024.

PUB: 11/13/2024 09:53 PM/DISC: 11/13/2024 09:53 PM

http://www.businesswire.com/news/home/20241113326286/en